18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Clinical trial NCT00696943 · TERMINATED

Trial details

NCT number: NCT00696943
Sponsor: Aposense Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastasis to Brain of Unknown Primary

Start date: 2008-07-01
Primary completion: 2009-07-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.